Walleye Trading’s GSK GSK Stock Holding History

Walleye Trading’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.55M	Buy	154,900 +81,200	+110%	+$4.4M	0.01%	874
2025 Q4	$3.61M	Buy	73,700 +44,100	+149%	+$2.06M	0.01%	1490
2025 Q3	$1.28M	Buy	29,600 +3,600	+14%	+$141K	﹤0.01%	2101
2025 Q2	$998K	Buy	26,000 +25,700	+8,567%	+$982K	﹤0.01%	2198
2025 Q1	$11.6K	Sell	300 -33,700	-99%	-$1.23M	﹤0.01%	3836
2024 Q4	$1.15M	Buy	34,000 +2,600	+8%	+$93.6K	﹤0.01%	2067
2024 Q3	$1.28M	Buy	31,400 +500	+2%	+$20.5K	﹤0.01%	1959
2024 Q2	$1.19M	Sell	30,900 -51,900	-63%	-$2.18M	﹤0.01%	1941
2024 Q1	$3.55M	Sell	82,800 -47,000	-36%	-$1.94M	0.01%	1357
2023 Q4	$4.81M	Sell	129,800 -42,800	-25%	-$1.54M	0.01%	1269
2023 Q3	$6.26M	Sell	172,600 -7,700	-4%	-$273K	0.02%	962
2023 Q2	$6.43M	Buy	180,300 +20,300	+13%	+$728K	0.02%	800
2023 Q1	$5.69M	Sell	160,000 -52,900	-25%	-$1.85M	0.01%	947
2022 Q4	$7.48M	Buy	212,900 +125,100	+142%	+$4.17M	0.02%	828
2022 Q3	$2.58M	Buy	87,800 +32,520	+59%	+$1.23M	0.01%	1505
2022 Q2	$3.76M	Sell	55,280 -30,160	-35%	-$1.66M	0.01%	1200
2022 Q1	$4.65M	Sell	85,440 -62,960	-42%	-$3.42M	0.01%	1050
2021 Q4	$8.18M	Sell	148,400 -24,880	-14%	-$1.29M	0.03%	708
2021 Q3	$8.28M	Buy	173,280 +123,760	+250%	+$6.22M	0.03%	642
2021 Q2	$2.46M	Buy	49,520 +31,600	+176%	+$1.52M	0.01%	1339
2021 Q1	$799K	Buy	17,920 +400	+2%	+$18.2K	﹤0.01%	2139
2020 Q4	$806K	Sell	17,520 -8,400	-32%	-$386K	﹤0.01%	2206
2020 Q3	$1.22M	Buy	25,920 +21,120	+440%	+$1.06M	0.01%	1496
2020 Q2	$245K	Sell	4,800 -7,680	-62%	-$394K	﹤0.01%	2917
2020 Q1	$591K	Buy	12,480 +10,480	+524%	+$559K	﹤0.01%	1738
2019 Q4	$117K	Buy	2,000 +1,040	+108%	+$57.9K	﹤0.01%	3481
2019 Q3	$51K	Sell	960 -7,840	-89%	-$403K	﹤0.01%	3566
2019 Q2	$440K	Sell	8,800 -53,520	-86%	-$2.69M	﹤0.01%	2292
2019 Q1	$3.25M	Buy	62,320 +42,320	+212%	+$2.11M	0.03%	745
2018 Q4	$955K	Sell	20,000 -10,560	-35%	-$520K	0.01%	1761
2018 Q3	$1.53M	Buy	30,560 +22,480	+278%	+$1.14M	0.01%	1621
2018 Q2	$407K	Sell	8,080 -11,360	-58%	-$572K	﹤0.01%	3025
2018 Q1	$949K	Buy	19,440 +3,680	+23%	+$171K	0.01%	1983
2017 Q4	$699	Sell	15,760 -28,480	-64%	-$1.32M	﹤0.01%	2280
2017 Q3	$2.25K	Sell	44,240 -6,000	-12%	-$304K	0.01%	1181
2017 Q2	$2.71K	Sell	50,240 -4,480	-8%	-$239K	0.02%	978
2017 Q1	$2.88K	Sell	54,720 -30,560	-36%	-$1.55M	0.02%	824
2016 Q4	$4.11M	Buy	85,280 +10,720	+14%	+$530K	0.03%	526
2016 Q3	$4.02M	Buy	74,560 +31,600	+74%	+$1.73M	0.03%	539
2016 Q2	$2.33M	Sell	42,960 -28,640	-40%	-$1.51M	0.02%	904
2016 Q1	$3.63M	Sell	71,600 -43,360	-38%	-$2.16M	0.03%	523
2015 Q4	$5.79M	Buy	114,960 +85,840	+295%	+$4.38M	0.06%	325
2015 Q3	$1.4M	Buy	29,120 +2,240	+8%	+$117K	0.01%	857
2015 Q2	$1.4M	Buy	26,880 +10,720	+66%	+$604K	0.01%	908
2015 Q1	$933K	Sell	16,160 -400	-2%	-$22.9K	0.01%	1057
2014 Q4	$882K	Sell	16,560 -19,120	-54%	-$1.07M	0.01%	1128
2014 Q3	$2.05M	Buy	35,680 +30,880	+643%	+$1.89M	0.02%	439
2014 Q2	$321	Buy	4,800 +3,600	+300%	+$244K	﹤0.01%	1616
2014 Q1	$79	Sell	1,200 -2,640	-69%	-$178K	﹤0.01%	2488
2013 Q4	$255K	Buy	3,840 +2,560	+200%	+$166K	﹤0.01%	2009
2013 Q3	$80K	Buy	1,280 +880	+220%	+$56.6K	﹤0.01%	2090
2013 Q2	$25K	Buy	+400	New	+$25.4K	﹤0.01%	2461

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Walleye Trading's GSK Position: Q1 2026 in Review

Walleye Trading opened a new position in GSK (GSK) in Q1 2026: 118,561 shares worth $6.54M. The stake represents 0.01% of the portfolio and ranks #989 among its holdings. This is a return to the name: Walleye Trading previously reported a position in GSK as recently as Q3 2025.

Walleye Trading first reported a position in GSK in Q2 2013 and has held it in 27 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Walleye Trading held 118,561 shares of GSK worth $6.54M as of Q1 2026.
GSK was a new Walleye Trading position in Q1 2026.
GSK made up 0.01% of Walleye Trading's portfolio in Q1 2026, its #989 holding.
Walleye Trading first reported a position in GSK in Q2 2013 and has held it in 27 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.